Viimane versioon :
18/04/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Viited 4506
Tüüp :
Ajaleht
Interneti link :
https://doi.org/10.1093/ajhp/zxaa296
Uurimisrühmad :
Phoenyx - Phoenix Children’s Hospital, Department of Pharmacy
Autor :
Griffith S, Stapleton E, Padilla S, Mruk A, Thomas C.
Pealkiri :
Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
Publikatsioon :
Am J Health-Syst Pharm ;77,23:1938-1940. 2020
Tõendite tase :
Füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
Ingredientide nimekiri
Amiodarone hydrochloride
1.8 mg/ml
+
Milrinone lactate
1 mg/ml
Bumetanide
0,25 mg/ml
+
Milrinone lactate
1 mg/ml
Epinephrine hydrochloride
32 µg/ml
+
Milrinone lactate
1 mg/ml
Furosemide
10 mg/ml
+
Milrinone lactate
1 mg/ml
Milrinone lactate
1 mg/ml
+
Amiodarone hydrochloride
1.8 mg/ml
1 mg/ml
+
Bumetanide
0,25 mg/ml
1 mg/ml
+
Epinephrine hydrochloride
32 µg/ml
1 mg/ml
+
Furosemide
10 mg/ml
1 mg/ml
+
Nicardipine hydrochloride
0,4 mg/ml
1 mg/ml
+
Norepinephrine bitartrate
0,032 mg/ml
Nicardipine hydrochloride
0,4 mg/ml
+
Milrinone lactate
1 mg/ml
Norepinephrine bitartrate
0,032 mg/ml
+
Milrinone lactate
1 mg/ml
Mentions Légales
